260 related articles for article (PubMed ID: 10381540)
1. Modulation of apolipoprotein D and apolipoprotein E expression in rat hippocampus after entorhinal cortex lesion.
Terrisse L; Séguin D; Bertrand P; Poirier J; Milne R; Rassart E
Brain Res Mol Brain Res; 1999 Jun; 70(1):26-35. PubMed ID: 10381540
[TBL] [Abstract][Full Text] [Related]
2. Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients.
Terrisse L; Poirier J; Bertrand P; Merched A; Visvikis S; Siest G; Milne R; Rassart E
J Neurochem; 1998 Oct; 71(4):1643-50. PubMed ID: 9751198
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of apolipoprotein D following experimental traumatic brain injury.
Franz G; Reindl M; Patel SC; Beer R; Unterrichter I; Berger T; Schmutzhard E; Poewe W; Kampfl A
J Neurochem; 1999 Oct; 73(4):1615-25. PubMed ID: 10501208
[TBL] [Abstract][Full Text] [Related]
4. Cellular cholesterol storage in the Niemann-Pick disease type C mouse is associated with increased expression and defective processing of apolipoprotein D.
Suresh S; Yan Z; Patel RC; Patel YC; Patel SC
J Neurochem; 1998 Jan; 70(1):242-51. PubMed ID: 9422368
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. Identification of apolipoprotein D, apolipoprotein A-IV, apolipoprotein E, and apolipoprotein A-I.
Boyles JK; Notterpek LM; Anderson LJ
J Biol Chem; 1990 Oct; 265(29):17805-15. PubMed ID: 2120218
[TBL] [Abstract][Full Text] [Related]
6. Hippocampal apolipoprotein D level depends on Braak stage and APOE genotype.
Glöckner F; Ohm TG
Neuroscience; 2003; 122(1):103-10. PubMed ID: 14596852
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization and differential mRNA tissue distribution of mouse apolipoprotein D.
Séguin D; Desforges M; Rassart E
Brain Res Mol Brain Res; 1995 Jun; 30(2):242-50. PubMed ID: 7637575
[TBL] [Abstract][Full Text] [Related]
8. Hippocampal alterations of apolipoprotein E and D mRNA levels in vivo and in vitro following kainate excitotoxicity.
Montpied P; de Bock F; Lerner-Natoli M; Bockaert J; Rondouin G
Epilepsy Res; 1999 Jun; 35(2):135-46. PubMed ID: 10372566
[TBL] [Abstract][Full Text] [Related]
9. Modulation of apolipoprotein D and apolipoprotein E mRNA expression by growth arrest and identification of key elements in the promoter.
Do Carmo S; Séguin D; Milne R; Rassart E
J Biol Chem; 2002 Feb; 277(7):5514-23. PubMed ID: 11711530
[TBL] [Abstract][Full Text] [Related]
10. Astrocytes synthesize and secrete the lipophilic ligand carrier apolipoprotein D.
Patel SC; Asotra K; Patel YC; McConathy WJ; Patel RC; Suresh S
Neuroreport; 1995 Mar; 6(4):653-7. PubMed ID: 7605920
[TBL] [Abstract][Full Text] [Related]
11. Increased apolipoprotein E mRNA in the hippocampus in Alzheimer disease and in rats after entorhinal cortex lesioning.
Zarow C; Victoroff J
Exp Neurol; 1998 Jan; 149(1):79-86. PubMed ID: 9454617
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein D mRNA expression is elevated in PDAPP transgenic mice.
Thomas EA; Sautkulis LN; Criado JR; Games D; Sutcliffe JG
J Neurochem; 2001 Dec; 79(5):1059-64. PubMed ID: 11739619
[TBL] [Abstract][Full Text] [Related]
13. Binding and repressive activities of apolipoprotein E3 and E4 isoforms on the human ApoD promoter.
Levros LC; Labrie M; Charfi C; Rassart E
Mol Neurobiol; 2013 Dec; 48(3):669-80. PubMed ID: 23715769
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning of the mouse apolipoprotein D gene and its upregulated expression in Niemann-Pick disease type C mouse model.
Yoshida K; Cleaveland ES; Nagle JW; French S; Yaswen L; Ohshima T; Brady RO; Pentchev PG; Kulkarni AB
DNA Cell Biol; 1996 Oct; 15(10):873-82. PubMed ID: 8892759
[TBL] [Abstract][Full Text] [Related]
15. Expression of somatostatin and somatostatin receptor subtypes in Apolipoprotein D (ApoD) knockout mouse brain: An immunohistochemical analysis.
Rajput PS; Billova S; Patel SC; Kharmate G; Somvanshi RK; Kumar U
J Chem Neuroanat; 2009 Sep; 38(1):20-33. PubMed ID: 19465111
[TBL] [Abstract][Full Text] [Related]
16. Cell-type specific expression and regulation of apolipoprotein D and E in human endometrium.
Germeyer A; Capp E; Schlicksupp F; Jauckus J; von Rango U; von Wolff M; Strowitzki T
Eur J Obstet Gynecol Reprod Biol; 2013 Oct; 170(2):487-91. PubMed ID: 23895740
[TBL] [Abstract][Full Text] [Related]
17. Absence of ApoE upregulates murine brain ApoD and ABCA1 levels, but does not affect brain sterol levels, while human ApoE3 and human ApoE4 upregulate brain cholesterol precursor levels.
Jansen PJ; Lütjohann D; Thelen KM; von Bergmann K; van Leuven F; Ramaekers FC; Monique M
J Alzheimers Dis; 2009; 18(2):319-29. PubMed ID: 19584433
[TBL] [Abstract][Full Text] [Related]
18. Cerebral Apolipoprotein-D Is Hypoglycosylated Compared to Peripheral Tissues and Is Variably Expressed in Mouse and Human Brain Regions.
Li H; Ruberu K; Karl T; Garner B
PLoS One; 2016; 11(2):e0148238. PubMed ID: 26829325
[TBL] [Abstract][Full Text] [Related]
19. Studies of ApoD
El-Darzi N; Mast N; Petrov AM; Dao T; Astafev AA; Saadane A; Prendergast E; Schwarz E; Bederman I; Pikuleva IA
Cell Mol Life Sci; 2021 Feb; 78(3):963-983. PubMed ID: 32440710
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization and differential mRNA tissue distribution of rabbit apolipoprotein D.
Provost PR; Weech PK; Tremblay NM; Marcel YL; Rassart E
J Lipid Res; 1990 Nov; 31(11):2057-65. PubMed ID: 2086704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
